4FRK | Crystal structure of BACE1 in complex with aminooxazoline xanthene 11a | date | 2012-06-26 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Whittington, D.A., Long, A.M. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.10 | ||||||||||||
ligand | DWD, GOL, IOD BindingDB | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Structure and Property Based Design of Aminooxazoline Xanthenes as Selective and Orally Efficacious, CNS Penetrable BACE Inhibitors for the Treatment of Alzheimer's Disease., Huang H, La DS, Cheng AC, Whittington DA, Patel VF, Chen K, Dineen TA, Epstein O, Graceffa R, Hickman D, Kiang YH, Louie S, Luo Y, Wahl R, Wen P, Wood S, Fremeau B, J Med Chem. 2012 Aug 28. PMID:22928914 |
Data retrieval |
View 4FRK in 3D |
Visual 3D analysis of 4FRK |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4FRK |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |